# Amgen Inc. (AMGN) — Q4-2018 Earnings Results

**Report date:** 2019-01-29 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2018

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Up 0.08%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.42 | N/A | +2.07% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS performance, highlighting their commitment to shareholder value. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> We are pleased with our EPS results this quarter.

> Our focus remains on delivering value to our shareholders.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report shows a positive surprise in EPS, which contributed to a slight increase in the stock price. The lack of revenue data and future guidance may leave investors cautious. The small stock movement suggests that while the EPS beat is a positive sign, investors are awaiting more comprehensive information on revenue and future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2018_